These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 18989119)

  • 81. Current WHO Guidelines and the Critical Role of Genetic Parameters in the Classification of Glioma: Opportunities for Immunotherapy.
    Yuan F; Wang Y; Ma C
    Curr Treat Options Oncol; 2022 Feb; 23(2):188-198. PubMed ID: 35182297
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Overview of recent advances in the classification of ependymomas in WHO CNS5 classification: Simplified approach to their integrated diagnosis.
    Gupta RK; Sharma A; Sharma MC
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S68-S72. PubMed ID: 35562136
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Tumor classification: molecular analysis meets Aristotle.
    Berman JJ
    BMC Cancer; 2004 Mar; 4():10. PubMed ID: 15113444
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Integrated phenotype-genotype approach in diagnosis and classification of common central nervous system tumours.
    Merve A; Millner TO; Marino S
    Histopathology; 2019 Sep; 75(3):299-311. PubMed ID: 30820974
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Circulating biomarkers of CNS tumors: an update.
    Ilhan-Mutlu A; Wagner L; Preusser M
    Biomark Med; 2013 Apr; 7(2):267-85. PubMed ID: 23547822
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The 2007 Revised World Health Organization (WHO) Classification of Tumours of the Central Nervous System: newly codified entities.
    Fuller GN; Scheithauer BW
    Brain Pathol; 2007 Jul; 17(3):304-7. PubMed ID: 17598822
    [No Abstract]   [Full Text] [Related]  

  • 87. The WHO 2021 Classification of Central Nervous System tumours: a practical update on what neurosurgeons need to know-a minireview.
    Torp SH; Solheim O; Skjulsvik AJ
    Acta Neurochir (Wien); 2022 Sep; 164(9):2453-2464. PubMed ID: 35879477
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Low-grade central nervous system tumors.
    Lopes MB; Laws ER
    Neurosurg Focus; 2002 Feb; 12(2):E1. PubMed ID: 16212318
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The World Health Organization Classification of Tumors of the Central Nervous System, Fifth Edition, 2021: A Critical Analysis.
    Miller DC
    Adv Tech Stand Neurosurg; 2023; 46():1-21. PubMed ID: 37318567
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Newly Recognized CNS Tumors in the 2021 World Health Organization Classification: Imaging Overview with Histopathologic and Genetic Correlation.
    Rigsby RK; Brahmbhatt P; Desai AB; Bathla G; Ebner BA; Gupta V; Vibhute P; Agarwal AK
    AJNR Am J Neuroradiol; 2023 Apr; 44(4):367-380. PubMed ID: 36997287
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Development of the WHO classification of tumors of the central nervous system: a historical perspective.
    Scheithauer BW
    Brain Pathol; 2009 Oct; 19(4):551-64. PubMed ID: 18771526
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Contributions and limitations of FISH analysis for the diagnosis of central nervous system tumors according to the 2021 WHO classification: Feedback from Sainte-Anne Hospital's Department of Neuropathology].
    Tauziède-Espariat A; Tartar A; Mehdi L; Pucelle N; Lacombe J; Berthaud C; Brigot E; Massé J; Métais A; Benzakoun J; Hasty L; Chrétien F; Varlet P
    Ann Pathol; 2023 Nov; 43(6):443-451. PubMed ID: 37385935
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Mesenchymal non-meningothelial tumors of the central nervous system: a literature review and diagnostic update of novelties and emerging entities.
    Tauziède-Espariat A; Hasty L; Métais A; Varlet P
    Acta Neuropathol Commun; 2023 Feb; 11(1):22. PubMed ID: 36737790
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Next-generation molecular diagnostics.
    Aldape K; Pfister SM
    Handb Clin Neurol; 2016; 134():121-30. PubMed ID: 26948351
    [TBL] [Abstract][Full Text] [Related]  

  • 95. World Health Organization Classification of Tumors of the Central Nervous System 5
    Mahajan S; Suri V; Sahu S; Sharma MC; Sarkar C
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S5-S13. PubMed ID: 35562129
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Classical pathology and basic concepts of the current WHO classification (5th edition) of central nervous system tumors].
    Scheich B; Rajnai H
    Magy Onkol; 2023 Dec; 67(4):289-303. PubMed ID: 38109508
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Critical remarks on the international WHO classification of rodent central nervous system (CNS) tumours.
    Krinke GJ
    Physiol Res; 1997; 46(2):89-91. PubMed ID: 9727498
    [No Abstract]   [Full Text] [Related]  

  • 98. Molecular pathogenesis of astrocytic tumours.
    Ichimura K; Ohgaki H; Kleihues P; Collins VP
    J Neurooncol; 2004 Nov; 70(2):137-60. PubMed ID: 15674475
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A retrospective analysis of practical benefits and caveats of the new WHO 2021 central nervous system tumor classification scheme in low-resource settings: "A perspective from low- and middle-income countries".
    Köy Y; Ceylan O; Kahraman A; Cangi S; Özmen S; Tihan T
    Neuropathology; 2024 Jun; 44(3):183-189. PubMed ID: 38029519
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Practical Implications of the Updated WHO Classification of Brain Tumors.
    Martinez-Lage M; Sahm F
    Semin Neurol; 2018 Feb; 38(1):11-18. PubMed ID: 29548047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.